A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide-Reference-Cited by-同舟云学术

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide

Published:2014-10 Issue:1 Volume:86 Page:59-66
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kotsakis Athanasios,Papadimitraki Elisavet,Vetsika Eleni Kyriaki,Aggouraki Despoina,Dermitzaki Eleftheria Kleio,Hatzidaki Dora,Kentepozidis Nikolaos,Mavroudis Dimitris,Georgoulias Vassilis

Funder

Cretan Association for Biomedical Research

Hellenic Society of Medical Oncology

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. Role of pemetrexed in non-small cell lung cancer;Longo-Sorbello;Cancer Investig,2007

4. Paclitaxel–carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients;Cancers;2024-06-28

2. Telomere-related DNA damage response pathways in cancer therapy: prospective targets;Frontiers in Pharmacology;2024-06-07

3. RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors;Molecular Therapy;2024-06

4. Telomere maintenance mechanisms in neuroblastoma: New insights and translational implications;EJC Paediatric Oncology;2024-06

5. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04